[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine

C11H16N4O2 — CID 103375762

IUPAC[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine
SMILESCOc1ccc(C(NN)C2=COCCC2)nn1
InChIInChI=1S/C11H16N4O2/c1-16-10-5-4-9(14-15-10)11(13-12)8-3-2-6-17-7-8/h4-5,7,11,13H,2-3,6,12H2,1H3
InChIKeyCLRNZVOAGLGUEF-UHFFFAOYSA-N
MW236.28 g/mol
LogP0.68
Rot. Bonds4

About [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine

[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine (PubChem CID 103375762) has the molecular formula C11H16N4O2 and a molecular weight of 236.28 g/mol. Its IUPAC name is [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine.

Molecular Properties

Compound Name[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine
PubChem CID103375762
Molecular FormulaC11H16N4O2
Molecular Weight236.28 g/mol
Exact Mass236.13
IUPAC Name[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine
SMILESCOc1ccc(C(NN)C2=COCCC2)nn1
InChIInChI=1S/C11H16N4O2/c1-16-10-5-4-9(14-15-10)11(13-12)8-3-2-6-17-7-8/h4-5,7,11,13H,2-3,6,12H2,1H3
InChIKeyCLRNZVOAGLGUEF-UHFFFAOYSA-N
XLogP0.68
TPSA82.29 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms17
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500236.28
LogP ≤ 50.68
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(5-bromo-2-pyridinyl)-(3,4-dihydro-2H-pyran-5-yl)methyl]hydrazine
CID 105267637
[3,4-dihydro-2H-pyran-5-yl-(3-fluoro-4-methoxyphenyl)methyl]hydrazine
CID 105333247
[(4-tert-butylphenyl)-(6-methoxypyridazin-3-yl)methyl]hydrazine
CID 103375681
[3,4-dihydro-2H-pyran-5-yl-(4-iodophenyl)methyl]hydrazine
CID 105333272
[3,4-dihydro-2H-pyran-5-yl-(2-methylsulfanylphenyl)methyl]hydrazine
CID 105333174
[3,4-dihydro-2H-pyran-5-yl-(3,4,5-trifluorophenyl)methyl]hydrazine
CID 105208035
[(3-chloro-4-methylphenyl)-(3,4-dihydro-2H-pyran-5-yl)methyl]hydrazine
CID 105333182
[3,4-dihydro-2H-pyran-5-yl-(2,5-dimethylpyrazol-3-yl)methyl]hydrazine
CID 105333213
N-[cyclohexen-1-yl-(6-methoxypyridazin-3-yl)methyl]ethanamine
CID 106654822
[3,4-dihydro-2H-pyran-5-yl-(4-methylthiophen-3-yl)methyl]hydrazine
CID 105251691
[(6-methoxypyridazin-3-yl)-(oxan-3-yl)methyl]hydrazine
CID 107139737
N-[[(1E)-cycloocten-1-yl]-(6-methoxypyridazin-3-yl)methyl]ethanamine
CID 106654823

Frequently Asked Questions

What is the IUPAC name of [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine?
The IUPAC name of [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine (CID 103375762) is [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine.
What is the SMILES notation for [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine?
The canonical SMILES for [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine is COc1ccc(C(NN)C2=COCCC2)nn1.
What is the InChIKey of [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine?
The InChIKey is CLRNZVOAGLGUEF-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H16N4O2/c1-16-10-5-4-9(14-15-10)11(13-12)8-3-2-6-17-7-8/h4-5,7,11,13H,2-3,6,12H2,1H3.
What are the key properties of [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine?
[3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine has a molecular weight of 236.28 g/mol, XLogP of 0.68, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [3,4-dihydro-2H-pyran-5-yl-(6-methoxypyridazin-3-yl)methyl]hydrazine is sourced from PubChem (CID 103375762), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).